Position in DHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,571
-$6,425 QoQ
Shares Held
24
-58.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,046
of 2,092 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MANNING & NAPIER ADVISORS LLC holds $976,966 across 8 Diagnostics & Research names. DHR ranks #5 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
3,663 | $776,372 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
335 | $167,955 | |
| 3 | NTRA |
Natera, Inc.
|
58 | $15,744 | |
| 4 | ILMN |
Illumina, Inc.
|
38 | $6,681 | |
| 5 | DHR |
Danaher Corp /De/
This page
|
24 | $4,571 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
14 | $3,175 | |
| 7 | GH |
Guardant Health, Inc.
|
16 | $2,400 | |
| 8 | GRAL |
GRAIL, Inc.
|
1 | $68 |
All Filings in DHR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,571 | 24 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,996 | 58 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,518 | 11 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $6,542 | 33 | Shares | Sole | 2025-10-27 | |
| 2025-03-31 | $72,006,455 | 351,251 | Shares | Sole | 2025-04-22 | |
| No filing history on record for this holder in this stock. | ||||||